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ORIGINAL INVESTIGATIONS 
Infusion of Five Percent Dextrose Increases Mortality and 
Morbidity Following Six Minutes of Cardiac Arrest in 
Resuscitated Dogs 
Edward F. Lundy, John E. Kuhn, Jennifer M. Kwon, Gerald B. Zelenock, and Louis G. D’Alecy 
The aim of this study was to assess the effect of 
dextrose administration during and following cardiac 
resuscitation on mortality and morbidity. Thirty-one 
dogs anesthetized with halothane were subjected to 
six minutes of ventricular fibrillation and were resus- 
citated with open chest cardiac message. All dogs 
were successfully resuscitated. Thirteen received no 
dextrose infusion and were fully ambulatory, eating 
and drinking at 24 hours. Ten of the 18 dogs receiv- 
S UDDEN CARDIAC ARREST is a leading cause of mortality in the United States, 
accounting for approximately 384,000 deaths per 
year.’ The standardization of cardiac life support 
protocols, the establishment of rapid response 
emergency medical systems, and the education 
and certification of both medical and lay person- 
nel have reduced the mortality associated with 
sudden cardiac arrest; however, mortality rates 
in most areas are still approximately 85%.2 Car- 
diac arrest protocols include the initial establish- 
ment of a venous access to facilitate drug admin- 
istration. The patency of this access is main- 
tained with a continuous infusion of fluids which 
routinely contain 5% dextrose. When an individ- 
ual is found unconscious and no history is avail- 
able, an ampule of 50% dextrose is frequently 
administered to correct for possible hypoglycem- 
ia. These uses of dextrose are generally consid- 
ered either beneficial or at least innocuous. The 
treatment groups in this study were specifically 
designed to evaluate the use of dextrose in an 
experimental model mimicking the clinical set- 
ting of cardiac arrest. 
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ing an infusion of 5% dextrose died before 24 hours 
and the eight that survived were profoundly 
impaired. Significantly greater neurologic deficits 
were recorded for dogs with higher blood glucose 
concentrations. We conclude that the inclusion of 
dextrose in fluids used in resuscitation increases 
mortality and morbidity. 
0 1987 by Grune & Stratton, inc. 
Several experimentaY* and clinica19x10 studies 
have demonstrated that hyperglycemia prior to 
primary cerebral ischemic events will increase 
mortality and the severity of the associated neu- 
rologic deficit. The potential clinical importance 
of postresuscitation blood glucose levels was 
recently suggested in a retrospective study of 
resuscitated patients.” Elevated blood glucose 
levels at the time of hospital admission were 
strongly correlated with an adverse neurologic 
outcome. However, the role of exogenous dex- 
trose administration in elevating blood glucose 
levels and exacerbating ischemic damage was not 
evaluated by these investigators. 
We recently demonstrated that 5% dextrose 
administered prior to cardiac arrest and resusci- 
tation increases the anticipated mortality and 
neurologic deficit.” However, in the vast major- 
ity of cardiac arrest cases, dextrose administra- 
tion begins during, rather than prior to, the 
resuscitation effort. In this study we tested the 
hypothesis that even the routine administration 
of dextrose solutions begun at the initiation of the 
resuscitation effort impairs survival following 
resuscitation from cardiac arrest. 
MATERIALS AND METHODS 
Animal Preparation and Experimental 
Procedure 
Thirty-one fed mongrel dogs (15.9 to 28.6 kg) were 
premeditated with morphine sulfate, (1.5 mg/kg IM). Anes- 
thesia was induced with 5% halothane via mask and demand 
ventilation. Once anesthetized, the dogs were intubated and 
maintained on 1% to 2% halothane (Foregger, Compact-75) 
via controlled ventilation (Bennett, Anesthesia Ventilator; 
Puritan Bennett Corp, Westmont, IL). Neuromuscular 
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blocking agents were not used. Carbon dioxide concentration 
in respiratory gas was continuously monitored (Beckman 
LB-2) with an infrared analyzer and end expiratory gas was 
maintained between 4% and 5%. Prearrest arterial blood 
glucose and pH measurements were made, and blood pH was 
adjusted to 7.41 by sodium bicarbonate administration, and 
carbon dioxide tension was adjusted by manipulating ventila- 
tion. An esophageal temperature probe was inserted to the 
level of the heart. Body temperature was monitored and 
maintained at 39 “C with a heating pad and proportional 
controller. An indwelling urethra1 catheter was placed to 
allow estimation of urine production. Two venous catheters 
were inserted: one through the external jugular vein to the 
superior vena cava for drug administration and central 
venous pressure monitoring and the other in the femoral vein 
for fluid infusion. A catheter was placed in the femoral artery 
to monitor pulsatile blood pressure and for the withdrawal of 
arterial blood samples. 
A left thoracotomy at the fifth intercostal space provided 
access to the heart, and the pericardium was opened to permit 
direct cardiac compression. Subcutaneous electrocardio- 
graphic electrodes were placed to monitor Lead II ECG. This 
ECG, along with mean and pulsatile arterial pressure, heart 
rate, and expiratory carbon dioxide tension were recorded on 
an oscillograph (Gould-Brush 200). When the preparation 
was complete, the dogs were disconnected from the anes- 
thesia machine and connected to a room air ventilator 
(Harvard 607) to reduce and standardize the level of anes- 
thesia at which fibrillation would be induced. The heart was 
fibrillated after cornea1 reflexes had consistently returned by 
delivering a 60-Hz, 2-ms square wave stimulus to the epicar- 
dial surface of the left ventrical. Circulatory arrest was 
confirmed by evaluation of the ECG tracing, arterial pressure 
pulse, and by direct observation. 
The resuscitation effort began with direct cardiac mas- 
sage, which maintained continuously monitored arterial 
blood pressure above 75 mm Hg. In all dogs drugs were 
rapidly injected into the central venous catheter in the 
following sequence and doses: the treatment fluid bolus; an 
epinephrine injection (20 pg/kg) and infusion (4 wg/kg,/min) 
(femoral venous catheter); an injection of NaHCO, (2 mEq/ 
kg); an injection of lidocaine (1 mg/kg); and an injection of 
CaCl, (25 mg/kg). As soon as this initial sequence of drugs 
was administered (approximately one minute) defibrillation 
was attempted by delivering a charge of 40 to 80 J (Lifepak-3 
Physio-Control; Redmond, WA), with 3 1 cm* paddles placed 
on the ventricular surface. Additional injections or charges 
were administered when indicated by arterial blood pressure 
and ECG tracings. Epinephrine infusion was adjusted to 
maintain mean arterial pressure between 100 and 125 mm 
Hg, and was stopped when the dog was capable of maintain- 
ing a mean pressure greater than 100 mm Hg, or at six hours 
postarrest. 
The chest was closed and evacuated when a stable rhythm 
and pressure developed. The dogs were ventilated until 
spontaneous ventilation ensued and were extubated upon the 
return of the gag reflex. The dogs were then placed in a cage 
where blood pressure, heart rate, ECG, and central venous 
pressure were continuously monitored for 24 hours using a 
standard dog jacket and swivel (Alice King Chatham Medi- 
cal Arts). An antibiotic (Polyflex, 6.6 mg/kg IM) was given 
to all dogs, and morphine sulfate (1.5 mg/kg IM) was used as 
needed when the dogs showed signs of pain or discomfort. 
After six minutes of circulatory arrest, resuscitation began 
following advanced cardiac life support protocols, which were 
modified for dogs. All dogs received an infusion of either 
lactated Ringers’s (n = 13) or 5% dextrose in lactated Rin- 
ger’s (n = 18). The infusion fluid was administered at a 
calibrated rate (IVAC 530) of 120 mL/h for the first six 
hours, and then at 65 mL/h for the next 18 hours. A subgroup 
of five of the 13 dogs in the lactated Ringer’s infusion group 
and five of the 18 in the 5% dextrose in lactated Ringer’s 
infusion group received a bolus injection of 50% dextrose. All 
other dogs received a bolus injection of lactated Ringer’s at 
the start of resuscitation. The volume of each bolus (11 to 21 
mL of solution) was adjusted to the dog’s body weight to give 
a volume corresponding to a dose of one 50-mL ampule of 
50% dextrose to a 70-kg man. Total fluid volumes and total 
dextrose for each group is given in Table 1. 
At one, two, six, and 24 hours postarrest, a neurologic 
score’* described in Table 2 ,was assigned. All scoring was 
done by two or more investigators who referred to written 
descriptions of each test condition. Postmortem examinations 
of the heart, lungs, and wound site were conducted to verify 
catheter placements and to identify hemorrhage, heartworm 
infestation, or any iatrogenic problem relating to the thora- 
cotomy or resuscitation that may have contributed to the 
death of any of the dogs. The entire experimental procedure 
conformed to the guidelines set by the American Physiolog- 
ical Society and was approved by the University of Michigan 
Unit for Laboratory Animal Medicine Vertebrate Animal 
Use Committee (D001068D). 
Data Analysis 
Statistical analysis was performed with the aid of the 
Michigan Interactive Data Analysis System (MIDAS) on an 
Amdahl 5860 computer. Comparison of model parameters 
were assessed with Student’s t-test. Both the Student’s t-test 
and nonparametric Kurskel-Wallis tests were used to evalu- 
Table 1. Treatment Groups 





LR infusion (n = 13) 
8 LR 1,911 None 
5 D50 1,911 0.36 
D5LR infusion (n 13 LR 1,911 4.74 = 18) 
5 D50 1,911 5.10 
Dogs were randomly assigned to either dextrose containing (D5LR) or dextrose free (LR) infusion groups. Each infusion group contained a 
subgroup of five dogs given an initial dextrose bolus, thus defining four treatments which varied only by total dextrose to be administered. 
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Neurologic deficit score (scaled 0- 100) addresses five catego- 
ries of function and increases with severity of damage. 
ate neurologic scores. Fisher’s exact test was used for survival 
data. All average data is expressed as mean + 1 SEM. The 
sample size (n) for all experiments is the number of animals. 
Exact P values are given except when P is greater than .OS 
where it is reported as nonsignificant (NS). 
RESULTS 
The average values of the two infusion treat- 
ment groups for the prearrest variables of opera- 
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tive time (anesthesia induction to fibrillation), 
heart rate, arterial blood pH, end-expiratory 
carbon dioxide, and arterial blood glucose were 
not found to be statistically different (Table 3). 
Body weight and mean arterial pressure were 
statistically higher in the group that was to be 
given 5% dextrose in lactate Ringer’s despite 
random assignment of animals to treatment 
groups. The subgroups receiving the additional 
bolus injection of 50% dextrose were not found to 
be statistically different in the prearrest, resusci- 
tation, or primary postarrest variables for cardio- 
vascular and respiratory function, survival time 
and neurologic deficit scores but tended to have a 
lower blood pH. The bolus subgroups were thus 
included in the two infusion treatment groups for 
subsequent analysis. 
All 31 dogs were successfully resuscitated. 
Figure 1 illustrates the time of death for each dog 
and the survival rate for each group. All 13 dogs 
that received lactated Ringer’s infusions were 
alive at 24 hours. Ten of 18 dogs (56%) receiving 
dextrose infusion were dead at 24 hours, and as 
early as 11 hours postresuscitation 9 of these 10 
dogs had died. Mortality was both early and 
excessive in dogs receiving the dextrose infusion. 
None of the dogs died from ventricular fibril- 
lation and all dogs had regained spontaneous 
ventilation with hyperpnea within less than two 
hours. All the animals that died had fixed and 
dilated pupils, little or no somatosensory 
Table 3. Prearrest Variables 
LR Infusion LR Infusion 
With Dextrose Without Dextrose 
Variable (Sample Size. 18) (Sample Size, 13) P 
Body weight (kg) 21.0 f 0.7 18.8 +- 0.7 .04 
Operative time 94 + 5 98 i: 9 NS 
(min) 
Mean arterial pres- 131 f 5 115 i 4 .02 
sure (mm Hg) 
Heart rate (beats/ 101 t 6’ 112 * 13 NS 
min) 
Arterial blood pH 7.38 t .02t 7.37 t ,025 NS 
(U) 
End-expired CO, 3.9 k 0.2 3.9 i 0.2 NS 
(96) 
Arterial blood glu- 143 f 6$ 140 f 9 NS 
case (mg/dL) 
Average prearrest values of the two infusion groups 
(mean + 1 SEM, P values, Student’s t analysis). 
*Value was obtained with a smaller sample size, 17. 
tValue was obtained with a smaller sample size, 8. 
$Value was obtained with a smaller sample size, 9. 
$Value was obtained with a smaller sample size, 12. 
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Fig 1. Percent survival for the group receiving the LR 
infusion (n = 13) (without dextrose) and the group receiv- 
ing 5% dextrose in LR (n = 18). Fisher’s exact test was 
used to compute the Pvalue at 24 hrs. All dogs receiving LR 
infusion were alive at 24 hours. 
response, and death was often preceded by con- 
vulsivelike activity, limb extension with arching 
of the back. Cardiopulmonary depresssion 
appeared secondary to progressive neurologic 
damage. Subsequent postmortem examination 
failed to reveal any iatrogenic problems related 
to the thoracotomy or resuscitation that could 
account for the death of any animal. 
There was no statistical difference detected in 
prearrest blood glucose concentrations (Table 3). 
Both groups had increased postarrest blood glu- 
cose levels (Table 4); however the dogs receiving 
the dextrose infusion had significantly higher 
postresuscitation glucose levels. The exogenously 
administered dextrose presumably added to that 
mobilized by the animal in response to stress. 
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The time from the beginning of resuscitation 
to the establishment of stable cardiac rhythm 
and a mean arterial blood pressure greater than 
75 mm Hg without external compression (resus- 
citation time) was not statistically different 
between groups (Table 5). Also, no difference 
was detected between the number of defibrillat- 
ing shocks, amount of lidocaine, NaHCO,, or 
morphine used. The time the animals required 
ventilatory assistance was not different at a P = 
.05 level despite an almost doubling of ventila.tion 
time in the group of dogs that received the 
dextrose infusion. There was no detectable dif- 
ference in the interval from arrest until the 
animals could be extubated; however, all animals 
receiving an infusion of lactated Ringer’s were 
extubated by three hours. In contrast, four of the 
18 dogs receiving DSLR infusion died while still 
intubated. 
A marked difference in epinephrine require- 
ments was observed for the dextrose infusion 
group (Table 5). This group required, on the 
average, approximately three times more 
(P = .05) epinephrine administered as injections 
than the lactated Ringer’s infusion group. Also, 
the length of time the dextrose infusion animals 
required an epinephrine infusion to maintain 100 
to 125 mm Hg mean arterial blood pressure was 
almost twice as long as that of the group without 
dextrose, but this difference did not reach statis- 
tical significance. (The time of infusion is 
reported because the epinephrine infusion rate 
was continually titrated to maintain a mean 
arterial pressure of 100 to 125 mm Hg). At six 
hours, the only animals requiring epinephrine 
infusion were in the dextrose infusion group (all 
Table 4. Postresuscitation Physiologic Measurements 
LR Infusion LR Infusion 
With Dextrose Without Dextrose 
Variable ” (Sample Size, 18) ” (Sample Size, 13) P 
Heart rate 6 h (beats/min) 11 168 f 11 13 146 zk 11 NS 
Heart rate 24 h (beats/min) 8 120 t 13 13 143 f 11 ,002 
Arterial blood glucose 1 h 
(mg/dL) 9 408 + 59 12 256 + 16 .Oll 
Arterial blood pH 1 h 8 7.40 * .04 11 7.44 + .03 NS 
End-expired CO, on ventila- 
tor (%) 16 4.2 ZL 0.2 13 4.1 + 0.1 NS 
End-expired CO, off ventila- 
tor (96) 16 3.4 2 0.2 13 3.1 i 0.2 NS 
End expired CO, off vent 20 
min later (%) 13 2.9 zk 0.2 8 2.4 i 0.2 NS 
Average postresuscitation values of the two infusion groups (mean + 1 SEM, P values, Student’s t analysis). Two “off ventilator’” end 
expiratory values are given: one as soon as value stabilized and the other 20 minutes after. 
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Table 5. Resuscitation Procedure Variables 140 l- 
LR Infusion LR Infusion 
With Dextrose Without Dextrose 
Variable (Sample Size. 18) (Sample Size, 13) P 
Resuscitation time 12.2 + 2.2 7.1*0.9 NS 
(min) 
No. of shocks 5il 321 NS 
Ventilation time 44 + 13’ 25 + 3 NS 
fmin) 
Extubation time 175 i 35t 125i24 NS 
(min) 
Epi injection dose 93.3 i 25.0 30.8 i: 6.0 .05 
hdkg) 
Epi infusion time 141 i 36 71 f 16 NS 
(min) 
Total NaHCO, dose 3.8 t 0.2 2.1 i 0.1 NS 
hEq/kg) 
Total lidocaine dose 6.4 k 1 6.4 i 1 NS 
fmg/kg) 
Calcium chloride 49 t 14 31 i 3 NS 
(mg/kg) 
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Average values of the two infusion groups taken during the 
resuscitation procedure (mean + 1 SEM, P values, Student’s t 
analysis). 
Fig 2. The bar at the far left indicates 1 SEM about the 
prearrest value of mean arterial pressure for each group. 
The box with arrows indicates the range in which pressure 
was controlled for the six hours following arrest and 
resuscitation. Sample size is next to data points. Values 
were taken just after six hours when pressure stabilized 
and at 7,12,18, and 24 hours postresuscitation. 
*Value was obtained with a smaller sample size, 16. 
tValue was obtained with a smaller sample size, 13. 
SValue was obtained with a smaller sample size. 17. 
having received a dextrose bolus) and the aver- 
age infusion rate at this time for the four animals 
was 2.6 pg/kg/ min, or more than half the initial 
infusion rate used to initiate resuscitation. 
Figure 2 indicates the mean arterial pressure 
from the end of the six-hour support period to 24 
hours, during which time no statistically signifi- 
cant differences in mean arterial pressure were 
detected. Heart rate at six hours was not statisti- 
cally different but at 25 hours it was higher in the 
group without dextrose (Table 4). Urine was 
collected for the one to two hours prior to and, 
when possible, for six hours after the arrest. No 
more than 850 mL of urine was collected during 
this eight hours despite the infusion or injection 
of approximately 800 mL of fluid. Thus, there 
was no suggestion of a glucose induced diuresis, 
hypotension, or reflex tachycardia. 
the sample size in the dextrose infusion group is 
reduced to 13 (5 of 18 dead) by six hours and to 8 
(10 of 18 dead) by 24 hours reducing the statisti- 
cal separation of these groups. This analysis 
clearly biases the data in favor of the dextrose 
group in that the dextrose group thus contains 
only the least impaired dogs while the no dex- 








The total neurologic deficit score (Table 2) at 
one, two, six, and 24 hours is illustrated in Fig 3. 
As early as one hour postarrest the dextrose 
infusion group had a significantly greater neuro- 
logic deficit score than the lactated Ringer’s 
group (Student’s t). This separation is retained 
at two, six, and 24 hours. If dead animals (score 
of 100) are excluded from such analysis (Fig 4), 
0 
1 2 6 24 
Hours After Arrest 
Fig 3. Postresuscitation neurologic deficit. Values are 
the total neurologic score for all dogs (including dead dogs 
as a maximum deficit of 100) (mean + 1 SEM, P values for 
Student’s t analysis). f5 LR infusion fn = 13); 0 DSLR 
infusion (n = 18). 
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i 2 6 24 
~-0.0142 
Hours After Arrest 
Postresuscitation neurologic deficit. Values are 
the total neurologic score for only the dogs which remained 
alive (mean i 1 SEM, P values for Student’s t analysis). 
Note the group receiving the LR infusion is identical in Figs 
3 and 4. fZI LR infusion: 0 DBLR infusion. 
introduced by this form of analysis the greater 
neurologic deficit in the group receiving dextrose 
is still apparent. 
In each group the motor component of the 
neurologic score contributed strongly to the total 
deficit (Fig 5). The respiratory, spinal nerve, and 
cranial nerve indices of neurologic deficit were 
less discriminating. They often failed to show 
deficits at 24 hours, and the spinal and cranial 
nerve performance was often near normal within 
the first six hours postarrest. When the motor 
deficit score was plotted relative to change in 
blood glucose concentration (postresuscitation/ 
prearrest), a neurologic deficit threshold was 
apparent as blood glucose values increased two- 
fold (Fig 6). 
DISCUSSION 
The idea that glucose is damaging during 
cerebral ischemic events is not entirely new, but 
it is substantially underappreciated in both 
experimental protocols and daily clinical prac- 
tice. Several studies have been published indicat- 
ing that hyperglycemia prior to a focal or global 
cerebral insult increases neurologic damage.5-‘0 
These studies have clinical relevance in many 
commonly occurring clinical events, such as 
stroke, cardiac arrest, cardiopulmonary bypass, 
and carotid clamping. Unfortunately, these stud- 
ies have, to date, had little impact on clinical 
r--J Motor 
m Conscionsness 
m Cranial Nerve 
m Spinal Nerve 
m Respiration 
All Dogs Live Dogs Only 
Fig 5. Components of total neurologic deficit at 24 
hours. The key at the left indicates the maximum value 
obtainable for each component. 
practice and, in particular, cardiopulmonary 
resuscitation protocols. 
Cardiac Arrest as a Model of Global 
Cerebral Ix-hernia 
Of the many models of global cerebral ischem- 
ia, the induction of cardiac arrest is potentially 
28 r 0 80 8 8 
Relative Change in Blood Glucose 
(PostresuscitationlPrearrest) 
Fig 6. Motor deficit following changes in blood glucose. 
The relative change in blood glucose is plotted on the 
horizontal axis as postresuscitation blood glucose concen- 
tration divided by the prearrest concentration. Doubling 
blood glucose is the threshold for increased motor deficit. 
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the most directly relevant to the clinical setting. 
However, there have been some important criti- 
cisms of studies using such models.13 One major 
problem is the high failure rate associated with 
many closed chest, external compression resusci- 
tation attempts in dogs. In one such study involv- 
ing 12 minutes of cardiac arrest, only 13 of 34 
dogs were successfully resuscitated.14 Such low 
resuscitation rates raise concerns about the unu- 
sual tolerance of the small subgroup of surviving 
animals. The reasons for low resuscitation rates 
are rarely defined, but this failure to resuscitate 
is certainly due, in part, to variable and inade- 
quate cerebral blood flow associated with closed 
chest compressions” which may lengthen the 
effective period of ischemia. These concerns 
make comparisons of data within and between 
such studies difficult at best. 
To obviate these problems, we chose to use 
open chest, direct cardiac compression to main- 
tain a mean arterial pressure greater than 75 mm 
Hg and to hold our circulatory arrest time to a 
controlled six minutes. Resuscitation attempts 
that use direct cardiac compression result in 
improved cerebral blood flo~,‘~,‘~ better mainte- 
nance of brain electrical activity,” and improved 
brain recovery.19,20 Of the last 86 dogs fibrillated 
for this and two other studies,12v2’ we resuscitated 
85, a failure rate of approximately 1.2%. These 
results suggest that more reliable and consistent 
data can be obtained in canine models of cardiac 
arrest and resuscitation when direct cardiac com- 
pression is used as an alternative to closed chest 
compression. It is important to note that we are 
not necessarily advocating direct cardiac com- 
pression as the preferred technique in the clinical 
setting because this approach has not been fully 
evaluated in a controlled study. 
Previous studies have reported that in canine 
and feline models, arrest times from 12 to 16 
minutes were required to consistently produce 
detectable neurologic deficits.‘4S22-26 This is in 
contrast to humans who often develop neurologic 
damage after as little as four to six minutes of 
global cerebral ischemia.15,27 This apparent dis- 
crepancy has caused the questioning of the clini- 
cal relevance of previous cardiac arrest studies. 
Many causes can be suggested for the relatively 
long arrest times required to produce damage in 
animal studies, such as cortical mass differences, 
cooling effects in the laboratory setting, and 
species differences. Our data indicate that the 
reported differences may, in part, be due to the 
detrimental effects of dextrose. Dextrose is fre- 
quently administered to humans in a clinical 
setting, but it is not consistently used in a labora- 
tory setting. We elected to begin resuscitation 
after only six minutes of cardiac arrest to more 
closely mimic clinically relevant arrest/resusci- 
tation times and to use dextrose-containing intra- 
venous fluids as they are used clinically. 
Another potential criticism of using cardiac 
arrest and resuscitation as a model of global 
cerebral ischemia is the concern over the use of 
multiple drugs and their interactions with each 
other and anesthetics. Although we could not 
completely eliminate this influence, we did 
reduce and control its impact. The drugs used 
during the resuscitation effort were the mini- 
mum doses and types required to maintain blood 
pressure and cardiac function. We chose halo- 
thane as our general anesthetic because it per- 
mits rapid induction and recovery and it has not 
been reported to have protective effects following 
cerebral ischemia, as reported for example in the 
use of barbiturate anesthesia.28 The level of anes- 
thesia for each animal was reduced and stan- 
dardized by inducing arrest after the cornea1 lid 
reflex had consistently returned. 
Ventilatory and blood pressure support was 
restricted to six hours and the level of support 
provided was recorded as an experimental vari- 
able. We chose to stop support at six hours to 
minimize and standardize the support given each 
animal. The fact that dogs receiving dextrose 
infusion required more pharmacologic support is 
interpreted as a detrimental effect of dextrose 
infusion. One might argue that continued blood 
pressure support would have “saved” the dogs 
that died after six hours. This might be true but 
would not change the conclusion that dogs given 
dextrose during resuscitation have greater mor- 
bidity and higher mortality than those given an 
infusion free of dextrose. Continuing intensive 
cardiorespiratory support for the full six hours 
favored the survival of the dextrose infusion 
group. Despite this more intensive support, the 
dextrose infusion group had the greater mortali- 
ty. 
As with any protocol involving neurologic 
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evaluations, complete objectivity is difficult to 
obtain. The neurologic evaluation used in this 
study is our modification’* of a neurologic assess- 
ment developed by Nemoto et alz3 and used by 
others in similar protocols.24 In order to minimize 
potential bias, at least two investigators per- 
formed every neurologic examination. For any 
result which was unclear, written descriptions of 
the various conditions were consulted and the 
examination was repeated until a score was 
agreed upon. Table 2 gives the contribution of 
each scored deficit. 
In this study the motor deficit component 
contributed most to the overall neurologic deficit 
score (Fig 5), perhaps due to the greater vulnera- 
bility of these functions compared to those con- 
trolled by the brain stem or spinal cord.3 Our 
functional assessments are consistent with histo- 
logic studies of brain tissue following arrest and 
resuscitation. These studies characteristically 
show damage in the cortex, basal ganglia, and 
cerebellum with relative sparing of the brain 
stem.3.29-37 Although morphine was used to alle- 
viate postoperative pain, no animal required 
morphine for more than 12 hours postarrest, and 
there was no difference detected between groups 
in the amount of morphine used. This permitted 
the 24-hour neurologic deficit score to be rela- 
tively free from the influence of anesthesia, anal- 
gesia, or sedation. 
Potential concern might arise regarding 
assigning a neurologic deficit score of 100 points 
to a dead dog. This could be misleading if the 
cause of death were ventricular fibrillation, hem- 
orrhage, or any other noncerebral cause. 
Although we cannot absolutely exclude the possi- 
bility that the deaths were unrelated to the 
neurologic impairment, the pattern of death for 
the ten dogs (10 of 31 tested) that died in this 
study before 24 hours was clearly suggestive of a 
primary cerebral event. Maximum deficit in 
cranial and spinal nerves was recorded prior to 
progessive depression of cardiopulmonary func- 
tion. The typical pattern was one of fixed and 
dilated pupils with limb extension and arching of 
the back suggestive of brain swelling. This pat- 
tern and the absence of any evidence of primary 
cardiopulmonary failure justify the inclusion of 
dead dogs (scored as a maximum neurologic 
deficit of 100) in the analysis of data as shown in 
Fig 3. Figure 4 shows the neurologic deficit data 
including only live dogs. Regardless of the type of 
statistical analysis the conclusion remains the 
same. 
Glucose and Ischemic Damage 
Since most cardiac arrests occur out of the 
hospital, prior administration of dextrose and the 
potential for a damaging role of elevated blood 
glucose in the outcome of resuscitated patients 
has not been a major clinical concern. Further- 
more, Pulsinelli7 has reported that the postreper- 
fusion administration of glucose in a four-vessel 
occlusion model of cerebral ischemia in the rat 
had no obvious neurologic consequences. How- 
ever, a recent study by Longstreth and Inui” 
reported that postresuscitation blood glucose lev- 
els taken at hospital admission were strongly 
correlated with neurologic outcome. They 
reported that patients who did not awaken after 
resuscitation had a mean blood glucose level of 
341 mg/dL, a value not uncommon in a clinical 
setting. The admitting blood glucose concentra- 
tion of those that awoke (262 mg/dL) and the 
subgroup that was without neurologic deficit 
(251 mg/dL) was significantly lower. They did 
not speculate on the possibility that dex.trose 
administration may have contributed to the 
greater neurologic damage they observed in 
patients with higher blood glucose. Our study 
specifically focused on the evaluation of dextrose 
administration begun after the insult of cardiac 
arrest to mimic a typical out-of-hospital arrest 
and resuscitation sequence. Administration of 
intravenous dextrose-containing fluids would 
contribute to the elevation of blood glucose 
which, particularly in low flow states, could 
increase glycolytic flux and potentially increase 
neurologic deficit. 
In a previous study” we confirmed the obser- 
vations of Pulsinelli et al7 and Meyers and 
Yamaguchi3 that pretreatment with glucose was 
detrimental. The current results indicate that 
dextrose administered after, as well as before, the 
initiation of cerebral ischemia can be damaging. 
Pulsinelli’s7 observation that postreperfusion 
administration of glucose is of no consequence is 
perhaps due to species differences, or possibly 
differences in the model, ie, partial cerebral 
ischemia may occur in the four vessel occlusion 
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model whereas total ischemia is assured during 
cardiac arrest. The duration and severity of the 
ischemic period, the rate at which reperfusion 
occurs and the existence and duration of reactive 
hyperemia or persistent low flow states may also 
contribute to differences in the response of these 
models of cerebral ischemia. Another possible 
explanation is the different method used for 
dextrose administration. Pulsinelli gave rats an 
intraperitoneal injection of D-glucose after reper- 
fusion, whereas we tested intravenous adminis- 
tration of both a bolus and a continuous 24-hour 
infusion of dextrose. The dextrose bolus alone 
was minimally damaging and the 24 hour dex- 
trose infusion was found to be damaging with or 
without the bolus of dextrose. 
Dextrose administration in the setting of 
experimental cardiac arrest and resuscitation is 
associated with greater neurologic deficit and 
mortality. In an attempt to refine this relation- 
ship, blood glucose levels and neurologic deficit 
were plotted using the postresuscitation blood 
glucose values and the motor deficit score. No 
strong correlation was found with the absolute 
values of blood glucose. However, when we plot- 
ted the relative change in blood glucose against 
motor deficit, we noted a threshold for damage at 
the point where blood glucose is increased 
approximately twofold (Fig 6). Others38-40 have 
reported a threshold effect when evaluating the 
role of tissue lactate in ischemic brain damage. 
During normal blood flow and oxygen tension, 
brain tissue lactate has been reported to be 
approximately 1.5 mmol/L/kg.41 This steady- 
state concentration could be maintained by a 
small, yet constant glycolytic metabolism and a 
constant flow of blood to remove lactate. Should 
blood flow (and hence 0, and glucose delivery 
change), it is conceivable that the balance 
between production and removal of lactate shifts 
such that tissue lactate increases. Cerebral blood 
flow 15 to 30 minutes after resuscitation follow- 
ing total global ischemia has been reported to be 
less than 20% of the original value.zs~42-48 This 
hypoperfusion phenomenon can last more than 
18 hours postresuscitation. Meyers3* and oth- 
ers39,40 have shown a threshold for damage exists 
when tissue lactate exceeds 16 to 20 mmol/L/kg. 
Presumably, this threshold can be reached when 
a marked reduction in cerebral blood flow is 
combined with an increase in blood glucose, a 
situation that will drive glycolytic flux and result 
in the production and accumulation of tissue 
lactate. Interestingly, Pulsinelli et al have shown 
in the four-vessel occlusion model of global cere- 
bral ischemia and reperfusion in the rat,’ that 
with an increase in blood glucose slightly more 
than twofold, histologic damage was detected in 
areas of the brain where blood flow was reduced 
to 15%, but no damage was detected where blood 
flow was reduced to 25%. Our analysis of a 
rather abrupt transition, or threshold, for cere- 
bral damage is consistent with this regional blood 
how analysis. We, however, draw attention to 
metabolic substrate delivery as a determining 
factor and not blood flow changes alone. In a 
state of prolonged ischemia, the addition of sup- 
plemental glucose to the blood, through an intra- 
venous infusion, would increase tissue lactate 
production and accumulation, which could cause 
progressive tissue damage. In a recent study from 
our laboratory,49 2-deoxyglucose was used to 
inhibit glycolytic metabolism in the setting of 
hyperglycemia-aggravated ischemic damage. In 
the Wistar rat, severe forebrain ischemia, but no 
mortality, is produced by permanent occlusion of 
the vertebral arteries and 20 minutes of occlusion 
of the carotid arteries. The addition of 3 g/kg 
glucose to the four-vessel occlusion model of 
cerebral ischemia produced 100% mortality in 24 
hours; however, the further addition of 1.6 g/kg 
2-deoxyglucose reduced the mortality to 40% 
and reduced morbidity. We concluded that aug- 
mented ischemic damage during hyperglycemia 
is a consequence of glycolytic flux because 2- 
deoxyglucose, which decreases glucose uptake 
and glycolytic flux, decreased mortality and 
morbidity. The infusion of 5% dextrose in the 
present study parallels the hyperglycemia in the 
rat study; however, it remains speculative 
whether a comparable inhibition of glycolytic 
metabolism would eliminate the augmented 
damage we observed in resuscitated dogs. Thus, 
we can only hypothesize that the mechanism of 
augmented damage is through glycolytic metab- 
olism to lactate. Hyperglycemia alone does not 
cause the damage, and the mechanisms of 
ischemic damage are manifold and beyond the 
scope of this study. 
Although the heart metabolizes lactate more 
readily than the brain, lactate accumulation in 
the myocardium is ultimately associated with 
DEXTROSE WORSENS RESUSCITATION OUTCOME 
depressed pump function.50 If hyperglycemia 
exacerbates myocardial lactate accumulation, 
then an additional component of the epinephrine 
dependency may have been the need for inotropic 
support of a failing heart. Thus, although we 
believe the brain is the primary site of hypergly- 
cemia-aggravated ischemic damage, we cannot 
exclude-and in fact would hypothesize-myo- 
cardial, renal, or other tissue damage as contrib- 
utors to overall morbidity and mortality. 
This study utilized a standardized and highly 
reproducible model of cardiac arrest and resusci- 
tation. The only experimental variable was the 
administration of clinically relevant doses of 
dextrose as an intravenous drip and/or bolus. 
While no specific mechanism was evaluated, this 
descriptive study indicates that dextrose admin- 
istration during and after resuscitation from car- 
diac arrest is associated with a greatly increased 
mortality and neurologic morbidity. Further, 
while all dogs were successfully resuscitated, 
those receiving dextrose infusions required sub- 
stantially greater cardiorespiratory support in 
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the postarrest period. These data suggest that in 
the halothane-anesthetized dog postarrest ad- 
ministration of dextrose may elevate the blood 
glucose concentration enough to increase mortal- 
ity and morbidity. With the accumulation of 
evidence supporting the injurious role of elevated 
blood glucose concentration during ischemic 
events, we propose that dextrose-containing 
intravenous fluids may impair recovery from 
cardiac arrest and thus should be avoided in this 
setting. 
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